J R Soc Med 2003;96:494-496
doi:10.1258/jrsm.96.10.494
© 2003 Royal Society of Medicine
Enteral stenting in 21 patients with malignant gastroduodenal obstruction
Tjun Tang MB BChir
Mike Allison MD MRCP 1
Irene Dunkley BSc RN 2
Phil Roberts MD MRCP 2
Richard Dickinson MD FRCP
Vascular Unit
1 and Transplant Unit, Addenbrooke's NHS Trust, Cambridge
2 Department of Medicine, Hinchingbrooke NHS Trust,
UK
Correspondence to: Dr R J Dickinson, Consultant gastroenterologist, Department
of Medicine, Hinchingbrooke Hospital, Hinchingbrooke Park, Huntingdon PE29
6NT, UK E-mail:
tjuntang{at}mail.com
 |
SUMMARY
|
|---|
Placement of an enteral stent is emerging as an effective alternative
to
surgery for symptomatic relief in patients with malignant
gastric outflow and
duodenal obstruction. We report experience
in a series of patients who had the
Wallstent enteral prosthesis
inserted.
21 consecutive patients with inoperable obstruction, median age 75 years,
had twenty-three procedures for insertion of the Wallstent under fluoroscopic
guidance. Stent implantation was successful in 18 patients (86%), all of whom
gained relief from nausea and vomiting. There were no short-term
complications. Median survival after the procedure was four months (longest
ten months), and no deaths were related to insertion.
The efficacy and lack of complications in this series support use of the
endoscopically placed stent for palliative management of malignant upper
gastrointestinal obstruction.
 |
INTRODUCTION
|
|---|
In a patient with malignant gastroduodenal obstruction, the
last few months
of life are often dominated by nausea and vomiting,
leading on to starvation.
Surgical palliation is possible with
construction of a bypassing
gastrojejunostomy but the morbidity
and mortality of surgery are high in these
debilitated patients;
furthermore, only half gain adequate symptomatic
relief.
1,2
An alternative to surgery in these circumstances is now offered
by enteral
stents inserted under endoscopic and fluoroscopic
guidance. This technique has
a good safety record but little
has been reported on long-term clinical
outcomes. We report
here our 3-year experience with endoscopic insertion of
the
Wallstent to relieve malignant gastrointestinal outflow obstruction.
 |
METHODS
|
|---|
21 consecutive patients with malignant upper gastrointestinal
strictures
were prospectively studied. Their disease was beyond
surgical cure and all had
nausea and vomiting. They were admitted
as inpatients for implantation of the
Wallstent (Boston Scientific
Microvasive), which was inserted under
fluoroscopic and endoscopic
guidance as previously
described.
3
Technical success was defined
as satisfactory stent deployment and
re-establishment of luminal
patency. Clinical outcome was recorded in terms of
relief of
intestinal obstruction and palliation of symptoms.
 |
RESULTS
|
|---|
Twenty-three procedures were attempted in 21 patients, whose
details are
summarized in
Table 1. Their
median age was 75
years (range 40-88). In two-thirds of cases the primary
cancer
was pancreatic.
Stent implantation was technically successful in 18 (85%) patients. On two
occasions a guidewire could not be passed because of the duodenal obstruction
and, in a third, a previously placed plastic biliary stent could not be
reached for removal, thus preventing enteral stent placement. These 3 patients
went on to have a laparoscopic gastrojejunostomy. In all the patients who had
successful stent placement, nausea and vomiting improved and caloric intake
returned to maintenance levels. There were no short-term complications. Stent
migration was seen in only one case, during initial placement. 2 patients who
were successfully stented reported abdominal pain after the procedure but this
responded to simple analgesia. 2 patients were readmitted with severe vomiting
at six and nine months, respectively. In one, tumour had overgrown the edge of
the prosthesis; in the other, distortion of the stent itself was causing
mechanical obstruction (Figure
1). In both cases further coaxial stents were inserted to bridge
the stenosis. 17 patients (94%) died during the follow-up period, all from
causes unrelated to the stent insertion. Median survival was four months,
longest ten months. One patient was lost to follow-up.
 |
DISCUSSION
|
|---|
Our experience with this series, conducted in a district general
hospital,
supports the findings from major
centres
4-6
that
more than 70% of patients with malignant upper gastrointestinal
strictures not amenable to surgery obtain relief from an endoscopically
placed
enteral stent. The dearth of information on long-term
outcomes reflects the
short life expectancy of these patients;
mean survival is about thirteen
weeks.
5,7,8
The reported complications
include ulceration caused by the stent
wires,
9 bleeding,
stent
migration, mechanical occlusion, and
perforation.
5,10,11
Technical
difficulties are few. In some instances unfavourable angulation
between the oesophagus and gastric antrum, or complete stenosis,
makes the
guidewire hard to pass. In our early experience there
was a tendency to pass
the stent distally, which with the forward
force generated by opening of the
stent led to less than ideal
placing. Stent migration was seen in only one
case, soon after
insertion, and tumour overgrowth in another; we cannot
comment
on whether these will be commonly encountered in the long term.
Perhaps the most troublesome complication is that, over time,
the stent can
shorten and straighten, leading to duodenal abutment
and obstruction
(
Figure 1). In one patient in
our care, whose
stent was inserted elsewhere, this led to perforation. Further
coaxial stents are readily deployed to bypass the obstruction.
 |
REFERENCES
|
|---|
- Monson JR, Donohue JH, McIlrath DC, Farnell MB, Ilstrup. DM. Total
gastrectomy for advanced cancer: a worthwhile palliative procedure.
Cancer 1991; 68:1863
-8[CrossRef][Medline]
- Kikuchi S, Tsutsumi O, Kobayashi N, et al. Does
gastrojejunostomy for unresectable cancer of the gastric antrum offer
satisfactory palliation? Hepatogastroenterology 1999; 46:584
-7[Medline]
- Soetikno RM, Carr-Locke DL. Expandable metal stents for
gastric-outlet, duodenal and small intestinal obstruction.
Gastrointest Endosc Clin N Am 1999; 9:447
-58[Medline]
- Yim HB, Jacobson BC, Saltzman JR, et al. Clinical outcome
of the use of enteral stents for palliation of patients with malignant upper
GI obstruction. Gastrointest Endosc 2001; 53:329
-32[Medline]
- Soetikno RM, Lichtenstein DR, Vandervoort J, et al.
Palliation of malignant gastric outlet obstruction using an endoscopically
placed Wallstent. Gastrointest Endosc 1998; 47:267
-70[CrossRef][Medline]
- Pinto IT. Malignant gastric and duodenal stenosis: palliation by
peroral implantation of a self-expanding metallic stent. Cardiovasc
Intervent Radiol 1997; 20:431
-4[CrossRef][Medline]
- Yates MR, Morgan DE, Baron TH. Palliation of malignant gastric and
small intestinal strictures with self-expandable metal stents.
Endoscopy 1998; 30:266
-72[Medline]
- Bethge N, Breitkreutz C, Vakil N. Metal stents for the palliation
of inoperable upper gastrointestinal stenoses. Am J
Gastroenterol 1998;93:643
-5[CrossRef][Medline]
- Feretis C, Benakis P, Dimopoulos C, et al. Palliation of
malignant gastric outlet obstruction with self-expanding metal stents.
Endoscopy 1996; 28:225
-8[Medline]
- De Baere T, Harry G, Ducreux M, et al. Self-expanding
metallic stents as palliative treatment of malignant gastroduodenal stenosis.
Am J Roentgenol 1997; 169:1079
-83[Abstract/Free Full Text]
- Canon CL, Baron TH, Morgan DE, Dean PA, Koehler RE. Treatment of
colonic obstruction with expandable metal stents: radiological features.
Am J Roentgenol 1997; 168:199
-205[Abstract/Free Full Text]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. E. Lopera, A. Brazzini, A. Gonzales, and W. R. Castaneda-Zuniga
Gastroduodenal Stent Placement: Current Status
RadioGraphics,
November 1, 2004;
24(6):
1561 - 1573.
[Abstract]
[Full Text]
[PDF]
|
 |
|